CCG
MJN

Cypress Capital Group’s Mead Johnson Nutrition Company MJN Stock Holding History

Cypress Capital Group’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-5,305
Closed -$375K – 200
2016
Q4 		$375K Buy
5,305
+752
+17% +$56K 0.09% 148
2016
Q3 		$360K Buy
4,553
+208
+5% +$17.7K 0.09% 143
2016
Q2 		$394K Sell
4,345
-20
-0.5% -$1.69K 0.09% 139
2016
Q1 		$371K Sell
4,365
-5,036
-54% -$375K 0.09% 138
2015
Q4 		$742K Buy
9,401
+1,920
+26% +$151K 0.18% 99
2015
Q3 		$527K Sell
7,481
-68
-0.9% -$5.59K 0.13% 129
2015
Q2 		$681K Sell
7,549
-725
-9% -$69.9K 0.16% 116
2015
Q1 		$832K Buy
8,274
+4,572
+124% +$461K 0.19% 103
2014
Q4 		$373K Buy
3,702
+523
+16% +$52.1K 0.09% 162
2014
Q3 		$306K Hold
3,179
– – 0.07% 173
2014
Q2 		$296K Hold
3,179
– – 0.07% 177
2014
Q1 		$264K Hold
3,179
– – 0.06% 181
2013
Q4 		$266K Hold
3,179
– – 0.07% 178
2013
Q3 		$236K Hold
3,179
– – 0.06% 186
2013
Q2 		$252K Buy
+3,179
New +$255K 0.05% 188

Other funds holding MJN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cypress Capital Group's MJN Position: Q1 2017 in Review

Cypress Capital Group sold out of Mead Johnson Nutrition Company (MJN) in Q1 2017, closing a stake of 5,305 shares — an estimated $375K sold.

Cypress Capital Group first reported a position in MJN in Q2 2013 and held it in 15 quarters. The position peaked at $832K in Q1 2015. 533 funds tracked by Wall St. Rank hold MJN as of Q1 2017.

  • Cypress Capital Group reported no remaining Mead Johnson Nutrition Company position as of Q1 2017 after selling out during the quarter.
  • Cypress Capital Group sold 5,305 Mead Johnson Nutrition Company shares in Q1 2017, an estimated $375K.
  • Cypress Capital Group first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 15 quarters.
  • Cypress Capital Group's Mead Johnson Nutrition Company position peaked at $832K in Q1 2015.
  • 533 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2017.

Based on Cypress Capital Group's 13F filing for Q1 2017, filed 15 May 2017.